WB
The startup develops anticancer drugs by utilizing predictive biomarkers and a structured research approach that includes target discovery, drug discovery, medicinal chemistry, and CMC processes. This enables healthcare providers to offer more effective treatments for cancer patients, ultimately improving patient outcomes and quality of life.
Updated 3 months ago
Funding
$41.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops anticancer drugs by utilizing predictive biomarkers and a structured research approach that includes target discovery, drug discovery, medicinal chemistry, and CMC processes. This enables healthcare providers to offer more effective treatments for cancer patients, ultimately improving patient outcomes and quality of life.